3 Médecins sans Frontières, 1211 Geneva, Switzerland.
4 University Hospitals of Geneva, Geneva, Switzerland.
5 Surveillance and Monitoring/Safety and Vigilance, Essential Medicines and Health Products, WHO, Geneva, Switzerland.
6 Service de Pharmacologie-Toxicologie, Faculté de Médecine PIFO, Université Versailles Saint-Quentin, CHU R Poincaré, AP-HP, Garches, France.
7 Médecins sans Frontières, Paris, France; UMR-Défense 8257, Université Paris Descartes, Université Paris Diderot, APHP Hôpital Necker, Paris, France.
8 Direction de la lutte contre la Maladie chez Ministère de la Santé, Department of the Ministry of Public Health, Kinshasa, Democratic Republic of Congo.
9 Lao-Oxford-Mahosot Hospital-Welcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; University of Oxford, Oxford, UK; WorldWide Antimalarial Resistance Network (WWARN) and Infectious Disease Data Observatory (IDDO), Oxford, UK.